Free Trial
NASDAQ:BWAY

Brainsway (BWAY) Stock Price, News & Analysis

Brainsway logo
$12.80 -0.18 (-1.39%)
Closing price 04:00 PM Eastern
Extended Trading
$12.78 -0.02 (-0.16%)
As of 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Brainsway Stock (NASDAQ:BWAY)

Key Stats

Today's Range
$12.60
$13.07
50-Day Range
$8.61
$13.22
52-Week Range
$5.67
$13.35
Volume
30,813 shs
Average Volume
67,615 shs
Market Capitalization
$241.92 million
P/E Ratio
64.00
Dividend Yield
N/A
Price Target
$14.25
Consensus Rating
Buy

Company Overview

Brainsway Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
45th Percentile Overall Score

BWAY MarketRank™: 

Brainsway scored higher than 45% of companies evaluated by MarketBeat, and ranked 645th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Brainsway has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Brainsway has only been the subject of 1 research reports in the past 90 days.

  • Read more about Brainsway's stock forecast and price target.
  • Earnings Growth

    Earnings for Brainsway are expected to grow by 100.00% in the coming year, from $0.08 to $0.16 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Brainsway is 64.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.21.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Brainsway is 64.00, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.17.

  • Price to Book Value per Share Ratio

    Brainsway has a P/B Ratio of 3.87. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Brainsway's valuation and earnings.
  • Percentage of Shares Shorted

    0.82% of the float of Brainsway has been sold short.
  • Short Interest Ratio / Days to Cover

    Brainsway has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Brainsway has recently increased by 21.41%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Brainsway does not currently pay a dividend.

  • Dividend Growth

    Brainsway does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.82% of the float of Brainsway has been sold short.
  • Short Interest Ratio / Days to Cover

    Brainsway has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Brainsway has recently increased by 21.41%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Brainsway has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Brainsway this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    1 people have added Brainsway to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Brainsway insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    19.00% of the stock of Brainsway is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 30.11% of the stock of Brainsway is held by institutions.

  • Read more about Brainsway's insider trading history.
Receive BWAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brainsway and its competitors with MarketBeat's FREE daily newsletter.

BWAY Stock News Headlines

Banks aren’t ready for this altcoin—are you?
Want to see why we believe this could be the next evolution of financial infrastructure? The old financial system is showing cracks—and this altcoin might be ready to take its place
Brainsway Ltd. ADR
See More Headlines

BWAY Stock Analysis - Frequently Asked Questions

Brainsway's stock was trading at $9.43 at the start of the year. Since then, BWAY shares have increased by 35.7% and is now trading at $12.80.
View the best growth stocks for 2025 here
.

Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) issued its earnings results on Tuesday, May, 13th. The company reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.02. The company had revenue of $11.54 million for the quarter, compared to the consensus estimate of $11.45 million. Brainsway had a net margin of 9.01% and a trailing twelve-month return on equity of 7.35%.
Read the conference call transcript
.

Brainsway (BWAY) raised $30 million in an IPO on Wednesday, April 17th 2019. The company issued 2,500,000 shares at $11.94 per share. Cantor acted as the underwriter for the IPO.

Shares of BWAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Brainsway investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Jabil (JBL), e.l.f. Beauty (ELF), Novo Nordisk A/S (NVO) and AppLovin (APP).

Company Calendar

Last Earnings
5/13/2025
Today
7/02/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BWAY
Fax
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$14.25
High Stock Price Target
$16.00
Low Stock Price Target
$12.50
Potential Upside/Downside
+11.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
64.00
Forward P/E Ratio
160.00
P/E Growth
N/A
Net Income
$2.92 million
Pretax Margin
10.22%

Debt

Sales & Book Value

Annual Sales
$41.02 million
Cash Flow
$0.25 per share
Price / Cash Flow
52.03
Book Value
$3.31 per share
Price / Book
3.87

Miscellaneous

Free Float
15,305,000
Market Cap
$241.92 million
Optionable
Not Optionable
Beta
1.40
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:BWAY) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners